TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
EOLS

Evolus Inc

Healthcare · Drug Manufacturers - Specialty & Generic

7.90$ -1.9% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Evolus Inc (EOLS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -42 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow EOLS
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-36 -13 -13 -26 -93 -58 -33 -85 -34 -18 -42
0.4 0.3 0.2 0.0 5.0 7.7 6.3 4.5 5.9 6.0 8.7
1.5 1.0 0.6 7.0 9.5 11 9.6 11 16 22 21
1.6 1.1 -6.7 18 -1.0 59 17 18
-7.3 5.4 -2.1 2.8 -21 36 -12 -34 -5.9 -6.6 -22
0.0 0.0 0.0 0.0 4.6 3.1 1.0 2.9 1.6 1.5 8.5
0.0 0.0 0.0 0.0 -23 12 4.0 -2.9 -1.6 -4.8 -8.5
-1.3 -1.3 -1.3 -0.2 73 103
36 13 14 -3.9 71 39 -28 -0.5 50 0.0 25
36 13 13 119 134 38 73 -4.1 45 47 17
-0.2 -0.2 -0.2 93 17 -7.3 44 -92 8.9 24 -33
-36 -13 -13 -26 -98 -61 -34 -88 -36 -19 -51

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?